These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4390815

  • 1. Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.
    Laddu AR, Somani P.
    J Pharmacol Exp Ther; 1969 Nov; 170(1):79-83. PubMed ID: 4390815
    [No Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T, Rowles G, Shropshire AT.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract] [Full Text] [Related]

  • 3. [Studies on the chronotropic and ionotropic effect of ICI 50.172].
    Kühn P, Niederberger M, Kummer F.
    Wien Klin Wochenschr; 1971 Sep 17; 83(37):655-8. PubMed ID: 4398732
    [No Abstract] [Full Text] [Related]

  • 4. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
    Somani P.
    Am Heart J; 1969 Jan 17; 77(1):63-71. PubMed ID: 5782851
    [No Abstract] [Full Text] [Related]

  • 5. Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172).
    Somani P, Laddu AR.
    J Pharmacol Exp Ther; 1969 Nov 17; 170(1):72-8. PubMed ID: 4390814
    [No Abstract] [Full Text] [Related]

  • 6. [Antidysrhythmic and hemodynamic effect of the beta-receptor blockader ICI 50172 (Practolol)].
    Thormann J, Hardewig A.
    Verh Dtsch Ges Kreislaufforsch; 1971 Nov 17; 37():280-4. PubMed ID: 4400960
    [No Abstract] [Full Text] [Related]

  • 7. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR, Robson RD.
    J Pharmacol Exp Ther; 1970 Oct 17; 175(1):168-77. PubMed ID: 4394302
    [No Abstract] [Full Text] [Related]

  • 8. [On Practolol (ICI 50172) a new beta-blocking agent with selective action on the myocardium].
    Novelli GP.
    Acta Anaesthesiol; 1969 Oct 17; 20(6):1089-110. PubMed ID: 4397729
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of action of a new adrenergic beta-receptor antagonist MJ 1999 in the prevention of halothane-adrenaline-induced and ouabain-induced ventricular tachycardia in the dog.
    Sharma PL.
    Indian J Med Res; 1967 Dec 17; 55(12):1357-65. PubMed ID: 5595584
    [No Abstract] [Full Text] [Related]

  • 10. Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.
    Hashimoto K, Nakayama K, Oshima T, Kumakura S.
    Experientia; 1971 Jun 17; 27(6):666-7. PubMed ID: 4397569
    [No Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation.
    Laddu R.
    Eur J Pharmacol; 1970 Feb 17; 9(2):129-35. PubMed ID: 4392344
    [No Abstract] [Full Text] [Related]

  • 12. Antagonism of epinephrine-induced cardiac arrhythmias by 4-(2-isopropylamino-1-hydroxyethyl)-methanesulfonanilide (MJ 1999) .
    Somani P, Fleming JG, Chan GK, Lum BK.
    J Pharmacol Exp Ther; 1966 Jan 17; 151(1):32-7. PubMed ID: 5902176
    [No Abstract] [Full Text] [Related]

  • 13. [Action of Practolol (ICI 50172) on some experimental arrhythmias].
    Novelli GP, Ristori M, Ariano M.
    Acta Anaesthesiol; 1969 Jan 17; 20(6):1111-21. PubMed ID: 4397730
    [No Abstract] [Full Text] [Related]

  • 14. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF, Schmitt H, Boissier JR.
    J Pharmacol Exp Ther; 1969 Jul 17; 168(1):116-26. PubMed ID: 5792677
    [No Abstract] [Full Text] [Related]

  • 15. [Diagnosis and therapy of the hyperkinetic heart syndrome].
    Lydtin H, Schnelle K, Lohmöller G, Kusus T.
    Verh Dtsch Ges Inn Med; 1969 Jul 17; 75():402-5. PubMed ID: 4395391
    [No Abstract] [Full Text] [Related]

  • 16. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD, Ekue JM, Pantridge JF, Shanks RG, Zaidi SA.
    Br J Anaesth; 1971 Jul 17; 43(7):720-1. PubMed ID: 4398093
    [No Abstract] [Full Text] [Related]

  • 17. Blockade of epinephrine- and ouabain-induced cardiac arrhythmias in the dog heart-lung preparation.
    Somani P, Lum BK.
    J Pharmacol Exp Ther; 1966 May 17; 152(2):235-42. PubMed ID: 4380269
    [No Abstract] [Full Text] [Related]

  • 18. [Butydrine in the treatment of arrhythmia caused by hypertensive drugs in the course of fluothane anesthesia].
    Leonardis G, Splendiani G, Azzarone G.
    Minerva Anestesiol; 1969 Oct 17; 35(10):1017-20. PubMed ID: 4394402
    [No Abstract] [Full Text] [Related]

  • 19. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG, Tay J.
    J Pharmacol Exp Ther; 1972 Feb 17; 180(2):302-16. PubMed ID: 4400889
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between heart rate and ouabain toxicity in the dog heart-lung preparation.
    Lahiri PK, Laddu AR.
    Jpn Heart J; 1973 Jul 17; 14(4):357-65. PubMed ID: 4542950
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.